Genetic Variation in CYP2R1 and GC Genes Associated With Vitamin D Deficiency Status

Abstract

This cross-sectional study enrolled 180 patients at a private family practice in Virginia. Total serum vitamin D concentrations were obtained weekly from January 30, 2013, through March 30, 2013, in consecutive patients regularly scheduled for laboratory work at the practice. Patients were categorized into 2 groups and analyzed for variant alleles in vitamin D receptor (VDR; rs2228570), cytochrome P450 2R1 (CYP2R1; rs10741657), 7-dehydrocholesterol reductase (DHCR7; rs12785878), and group-specific component (GC; rs2282679) to determine whether variants of those alleles influenced total serum 25(OH)D concentrations. One-hundred and eighty patients were enrolled, with 40 (22%) being sufficient, 25-hydroxy vitamin D level 25(OH)D ≥ 30 ng/mL, and 140 (78%) being insufficient, 25(OH)D < 30 ng/mL. Of the 4 genes, 2 genes, CYP2R1 (rs10741657) and GC (rs2282679), demonstrated a significant association related to vitamin D status. Subjects with 1 or more variant alleles at rs10741657 were almost 3.7 (odds ratio [OR] 3.67; 95% confidence interval [CI]: 1.35-9.99) times more likely be insufficient in vitamin D and subjects with 1 or more variant alleles at rs2282679 were about half (OR 0.42; 95% CI: 0.18-0.93) as likely to be insufficient in vitamin D. Allelic variations in CYP2R1 (rs10741657) and GC (rs2282679) affect vitamin D levels, but variant alleles on VDR (rs2228570) and DHCR7 (rs12785878) were not correlated with vitamin D deficiency, 25(OH)D < 30 ng/mL.

Keywords

genetics vitamin D deficiency rs2228570 rs10741657 rs12785878 rs2282679

Get full access to this article

View all access options for this article.

References

Holick

. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.

Haines

Park

. Vitamin D supplementation: what’s known, what to do, and what’s needed. Pharmacotherapy. 2012;32(4):354–382.

The National Osteoporosis Foundation. Vitamin D and Bone Health. February 2012. Available from: http://nof.org/files/nof/public/content/clinicalupdates/clinicalupdates/Issue25VitaminD/2012_VitaminD.html. Accessed May 9, 2015.

Giovannucci

. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005;16(2): 83–95.

Zhang

Wang

. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol. 2011;29(28):3775–3782.

Lappe

Travers-Gustafson

Davies

. Vitamin D and calcium supplementation reduce cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586–1591.

Giovannucci

Liu

Hollis

. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med. 2008;168(11):1174–1180.

Brondum-Jacobsen

Benn

Jensen

. 25-Hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012;32(11):2794–2802.

Wang

Pencina

Booth

. Vitamin D deficiency and risk of cardiovascular disease. Circulation.2008;117(4):503–511.

10.

Levin

Robinson-Cohen

Boer

. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012;308(18):1898–1905.

11.

De Boer

Levin

Robinson-Cohen

. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med. 2012;156(9):627–634.

12.

Autier

Gandini

. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730–1737.

13.

Holick

Binkley

Bischoff-Ferrari

. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guidelines. J Clin Endocrinol Metab. 2011;96(7):1911–1930.

14.

Armas

Hollis

Heany

. Vitamin D₂ Is much less effective than vitamin D₃ in humans. J Clin Endocrinol Metab. 2004;89(11):5387–5391.

15.

Shea

Benjamin

Dupuis

. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2009;63(4):458–464.

16.

Engelman

FIngerlin

Langefeld

. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008;93(9):3381–3388.

17.

Hussein

Mohamed

Alghobashy

. Synergism of CYP2R1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Cell Immunol. 2012;279(1):42–45.

18.

Cheng

Levine

Bell

. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A. 2004;101(20):7711–7715.

19.

Engelman

Meyers

Iyengar

. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr. 2013;143(1):17–26.

20.

Koo

Conley

Wassif

. Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome. Am J Med Genet A. 2010;152A(8):2094–2098.

21.

Ahn

Stolzenberg-Solomon

. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19(13):2739–2745.

22.

Perna

Felix

Breitling

. Genetic variations in the vitamin D binding protein and season-specific levels of vitamin D among older adults. Epidemiology. 2013;24(1):104–109.

23.

Wang

Zhang

Richards

. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180–188.

24.

Trabert

Malone

Dalling

. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res. 2007;9(6):R84.

25.

Grant

Hoyo

Akushevic

. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol Oncol. 2013;129(1):173–178.

26.

Zeljic

Supic

Stamenkovic Radak

. Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med. 2012;41(10):779–787.

27.

Sinotte

Diorio

Berube

. Genetic polymorphisims of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr. 2009;89(2):634–640.

28.

Bischof

Heinze

Vierhapper

. Vitamin D status and its relation to age and body mass index. Horm Res. 2006;66(5):211–215.

29.

Arunabh

Pollack

Yeh

. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88(1):157–161.

30.

Lagunova

Porojicu

Lindberg

. The dependency of vitamin D status on body mass index, gender, age, and season. Anticancer Res. 2009;29(9):3713–3720.

31.

Holick

Matsuoka

Wortsman

. Age, vitamin D, and solar ultraviolet. Lancet. 1989;2(8671):1104–1105.